With 25 years in the bio/pharmaceutical industry, Jeff brings a unique combination of strategic and operational experiences.  After earning his MBA from the Boston University Questrom School of Business, he embarked on a career that has spanned large, mid-size, and small companies such as Eli Lilly, Boehringer Ingelheim, Merck Serono, Alexion, and Alnylam.  Adaptable and diverse, he has worked in over 15 countries, and lived abroad for 25% of his career.  Jeff has held leadership positions in marketing & sales, general management, and international corporate strategy, across all therapeutic areas spanning rare diseases, oncology, primary care, and specialty care. 

Jeff is currently the General Manager of Alnylam Canada, and is a Board Member of BIOTECanada.